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Breakthrough advances in intravital imaging have launched a new era for the study
of dynamic interactions at the neurovascular interface in health and disease. The
first Neurovascular and Immuno-Imaging Symposium was held at the Gladstone
Institutes, University of California, San Francisco in March, 2015. This highly
interactive symposium brought together a group of leading researchers who discussed
how recent studies have unraveled fundamental biological mechanisms in diverse
scientific fields such as neuroscience, immunology, and vascular biology, both under
physiological and pathological conditions. These Proceedings highlight how advances
in imaging technologies and their applications revolutionized our understanding of the
communication between brain, immune, and vascular systems and identified novel
targets for therapeutic intervention in neurological diseases.
Keywords: neuroinflammation, multiple sclerosis, traumatic brain injury, Alzheimer’s disease, blood-brain barrier,
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INTRODUCTION
The presentations at the first Neurovascular and Immuno-Imaging Symposium covered a broad
range of topics, from physiological neurovascular coupling in the brain to cellular and molecular
responses at the blood brain barrier (BBB), to recent developments in molecular imaging,
bioengineering, and the identification of novel therapeutic targets for human disease. A common
thread among the presentations was the study of the nervous system in health and disease using
imaging technologies and molecular tools for recording ongoing biological processes in living
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organisms, from mice to humans (Figure 1). Brief outlines of
the presentations together with a discussion of the imaging
approaches used and the implications of the findings for
better understanding of normal brain function or pathological
processes in disease, have been grouped in the following five
thematic areas.
IMAGING NEUROVASCULAR COUPLING
Physiological brain function relies on a large number of
interconnected cellular, metabolic, and vascular processes.
The term neurovascular coupling describes the relationship
between neural activity and metabolism with alterations in
cerebral blood flow (CBF). Though the interaction among these
processes is well established, the mechanisms linking them and
their importance for brain function remain largely unknown.
Functional neurovascular coupling refers to the local modulation
of CBF that occurs at sites of neural activity in the brain (Kozberg
et al., 2013; Hillman, 2014).
Many brain cell types link neural activity and vessel dilation,
including astrocytes (Takano et al., 2005), interneurons (Cauli
et al., 2004), and pericytes (Hall et al., 2014). However,
many features of the cortical hemodynamic response to neural
activity are unaccounted for by proposed models. Dr. Elizabeth
Hillman presented work from her group, demonstrating that
the vascular endothelium plays a role in this active coupling
process by propagating vasodilatory signals upstream to pial
arterioles (Chen et al., 2014). This pathway, which is known
to provide local blood flow modulation elsewhere in the body,
has many component mechanisms with different spatiotemporal
properties and pharmacological sensitivities (e.g., COX and
NO dependent and independent mechanisms; Wölfle et al.,
2011) and can explain many of the previously anomalous
results of earlier studies. Moreover, dependence of neurovascular
coupling on healthy endothelial function implicates a far
wider range of systemic cardiovascular disorders as having
direct cerebrovascular impact. A state in which endothelial
coupling is impaired could lead to neurodegeneration, or
even acute cognitive deficiencies. Equally, drugs, such as
those aimed at treating blood pressure, inflammation and
pain, which act directly on pathways within the vascular
endothelium, might affect neurovascular coupling (Bakalova
et al., 2002).
Dr. David Kleinfeld presented optical imaging studies
that could explain reported resting-state functional magnetic
resonance imaging (fMRI) observations correlating neuronal
activity in different parts of the brain and slow alterations in
blood oxygen levels. fMRI is a powerful tool to probe the extent
of activity in the human brain, and the blood-oxygenation-
level-dependent (BOLD) fMRI signal (Ogawa et al., 1990) in
particular, forms the central technology of modern cognitive
neuroscience. An intriguing issue is that ultra-slow variations
(∼0.1Hz) in brain tissue oxygenation appear mirrored across
conjugate brain areas of the two hemispheres (Biswal et al.,
1995). The discovery of this “resting-state” BOLD fMRI (Fox and
Raichle, 2007) has been inverted in human cognition studies,
so that ultra-slow co-fluctuations are interpreted as function
FIGURE 1 | Five thematic areas discussed at the Neurovascular and
Immuno-Imaging Symposium. Etching entitled “Mind on Fire” kindly
provided by Elizabeth Jameson.
connections (Sporns et al., 2005). Yet a mechanism explaining
this observation has been lacking. The Kleinfeld group used
ultra-large field two-photon laser scanning microscopy (Tsai
et al., 2015) in mice with a thin-skull transcranial window
(Drew et al., 2010), together with conventional techniques,
to perform microscopic measurements of neuronal activity,
vascular dynamics, and tissue oxygenation. They discovered
evidence for a biophysical basis linking the co-activation of
ongoing neuronal activity with ultra-slow oscillations in blood
oxygenation that could justify inferring neuronal connections
from synchronous ultra-slow vasodynamics across different
brain areas.
IMAGING THE BLOOD-BRAIN BARRIER
Neuronal computation and normal brain function requires tight
control of the chemical composition of the neuronal “milieu” that
is maintained by the BBB (Zlokovic, 1995; Zlokovic et al., 2010).
Brain endothelial cells tightly interconnected through adherens
and tight junctions (TJs) are the building blocks of the barrier,
while astrocytes and pericytes are essential for BBB formation
and maintenance. The BBB plays a pivotal role for the healthy
central nervous system (CNS) as it regulates the access of blood-
borne solutes to the brain and spinal cord, and limits the entry of
neurotoxic plasma-derived proteins, circulatingmetals, red blood
cells and leukocytes into the brain.
Dr. Berislav Zlokovic discussed the role of pericytes for BBB
breakdown, particularly in the context of neurodegenerative
disease. Studies from his group in transgenic murine models
have shown that chronic BBB breakdown caused by pericyte
degeneration or aberrant signaling to pericytes from endothelial
cells or astrocytes leads to accumulation of blood-derived
neurotoxic proteins in the CNS (e.g., fibrin, thrombin,
hemoglobin, free iron, plasmin; Bell et al., 2010, 2012).
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This causes progressive neurodegeneration mediated by direct
neuronal toxicity, oxidant stress and/or detachment of neurons
from the extracellular matrix (Bell et al., 2010, 2012). Pericytes
degenerate in Alzheimer’s’ disease (AD) that is associated with
BBB breakdown in human post-mortem studies (Sengillo et al.,
2013; Halliday et al., 2016). Accelerated pericyte degeneration in
a murine model of AD leads to BBB breakdown and increased
accumulation of Alzheimer’s toxin amyloid-β (Sagare et al.,
2013). Using a high resolution dynamic contrast-enhanced
magnetic resonance (MR) imaging protocol to quantify regional
BBB permeability in the human brain, they showed BBB
breakdown during normal aging that begins in the hippocampus
(a region critical for learning and memory), worsens with
mild cognitive impairment, and correlates with pericyte injury
(Montagne et al., 2015).
Although BBB breakdown is a hallmark of many neurological
disorders like AD, ischemic stroke and multiple sclerosis (MS;
Zlokovic, 2008), the cellular mechanism of BBB disruption
in different diseases is not established. In the healthy CNS,
endothelial cells regulate both paracellular and transcellular
access through the BBB via the presence of TJs and scarce
endocytotic vesicles, respectively. Dr. Dritan Agalliu presented
his group’s studies of structural and functional BBB changes using
in vivo two-photon microscopy in animal models of ischemic
stroke and neuroinflammatory disease. Using a novel transgenic
mouse strain with eGFP-labeled TJs (Tg eGFP-Claudin5) they
found that TJs break down between 24 and 48 h after occlusion
in the transient Middle Cerebral Artery Occlusion animal
model (t-MCAO). However, BBB function was impaired as
early as 6 h after stroke, a time point at which they found an
increased rate of transcytosis within endothelial cells (Knowland
et al., 2014). These findings suggest a stepwise impairment in
transcellular followed by paracellular pathways that contribute
to BBB breakdown in ischemic stroke. Moreover, Caveolin-
1 deficient mice, that have reduced transcellular permeability,
display a normal increase in paracellular permeability after t-
MCAO, suggesting that these two mechanisms are independent
(Knowland et al., 2014). In similar studies in the MS
animal model Experimental Autoimmune Encephalomyelitis
(EAE), they found that recycling of TJ proteins was faster
in the spinal cord than in the cortex, which may underlie
the preferential vulnerability of the spinal cord to EAE.
Moreover, dynamic changes in TJs occur prior to EAE onset
and throughout the disease. In contrast, BBB transcytosis
increases at peak EAE and Caveolin1−/− mice exhibit decreased
peak severity and demyelination. These findings suggest that
TJ disruption is necessary for the onset of EAE, whereas
transcellular permeability enhances disease severity. Moreover,
the kinetics of paracellular vs. transcellular impairment in
BBB function is quite different between ischemic stroke
and EAE.
MAGING NEUROVASCULAR
INFLAMMATION
BBB disruption, microglial activation and neurodegeneration
are hallmarks of MS (Lassmann et al., 2001; Dutta and
Trapp, 2014). However, whether plasma proteins contribute
to neuroinflammation and neuronal damage remains poorly
understood. Studies in human MS have identified abundant
deposition of the blood coagulation factor fibrinogen, not only
in active and chronic plaques, but also in early lesions prior to
demyelination (Kwon and Prineas, 1994; Claudio et al., 1995;
Gay et al., 1997; Vos et al., 2005; Marik et al., 2007; Han
et al., 2008). Dr. Katerina Akassoglou discussed her group’s
studies that identified fibrinogen-induced microglial activation
as a critical mediator of axonal damage in neuroinflammation
(Adams et al., 2007; Davalos et al., 2012, 2014; Bardehle et al.,
2015). Using in vivo two-photon microscopy, they showed that
in EAE, microglia specifically cluster around blood vessels with
BBB disruption at sites of perivascular fibrin deposition even
prior to disease onset (Davalos et al., 2012). By developing
a molecular probe to detect coagulation activity in the CNS,
they demonstrated early activation of coagulation and fibrin
deposition even before onset of EAE (Davalos et al., 2014).
Intriguingly, fibrin is sufficient to induce reactive oxygen species
release by microglia, and thus contribute to neurodegeneration
(Davalos et al., 2012). Pharmacologic or genetic disruption of
the interaction between fibrin and the CD11b/CD18 integrin
receptor (other names Mac-1, complement receptor 3) on
microglia suppresses microglial cluster formation, neurological
symptoms, inflammation, demyelination, and axonal damage
in EAE (Adams et al., 2007; Davalos et al., 2012). Overall,
their studies identified fibrinogen as a novel activator of
CNS innate immunity that promotes neurodegeneration. Fibrin
has the potential for selective drug targeting to suppress its
damaging functions in the nervous system without affecting its
beneficial effects in hemostasis (Adams et al., 2007; Davalos
and Akassoglou, 2012; Davalos et al., 2012; Bardehle et al.,
2015; Ryu et al., 2015). Fibrin-selective inhibition of innate
immunity may offer novel strategies to combat axonal damage
in neuroinflammatory disease.
BBB disruption through the compromise of the TJs of the non-
fenestrated endothelium comprising the cerebral and meningeal
blood vessels can also be the result of CNS infections and
injuries. The resulting unregulated passage of blood-derived
materials into the cerebrospinal fluid and CNS parenchyma can
in turn give rise to neurological dysfunction, seizures, edema, and
ultimately, fatal herniation if unrelieved. Dr. Dorian McGavern
discussed recent studies showing that both mechanical and
immunological factors can contribute to alterations in the
integrity of CNS vasculature (Kim et al., 2009; Roth et al.,
2014). Following traumatic brain injury (TBI), mechanical forces
stemming from the injury itself can open and / or occlude CNS
vasculature, even when the injury is mild (Roth et al., 2014;
Corps et al., 2015). This can trigger regional hypoxia, edema,
and cell death, resulting in the mobilization of a sterile immune
reaction driven by purinergic receptor signaling. Moreover, CNS
infection by viruses, bacteria, parasites, and fungi can similarly
open cerebral vasculature, yet through different mechanisms
(Kang and McGavern, 2010). Meningitis and encephalitis are
commonly observed following CNS infection and result from the
recruitment of immune cells into the meninges or parenchyma,
respectively (Swanson andMcGavern, 2015). Innate and adaptive
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immune cells are recruited to the CNS to clear invading
pathogens, but sometimes the manner by which these cells are
recruited promotes vascular injury. Intravital imaging studies
by his group revealed that pathogen-specific CD8+ T cells can
promote synchronous extravasation of innate myelomonocytic
cells through release of chemoattractants (Kim et al., 2009;
McGavern and Kang, 2011). This type of extravasation is
incredibly injurious to CNS vasculature and contributes to
seizures and fatal edema. Thus, while the mechanisms of vascular
breakdown may differ between infections and injuries, the
resultant neurological complications stemming from a loss in
CNS barrier integrity are often similar.
IMAGING CELLULAR MECHANISMS IN
NEUROLOGICAL DISEASE
Dr. Jaime Grutzendler discussed novel methods for longitudinal
imaging of the brain microvasculature and myelinated axons
in vivo and presented new biological discoveries made with such
techniques. The fibrinolytic system has been recognized as the
principal mechanism in charge of clearing the vasculature from
occluding thromboemboli. Two photon microscopy of cortical
capillaries in vivo revealed an additional innate mechanism
of microvascular recanalization capable of clearing emboli
composed of a variety of substances including those not
susceptible to fibrinolysis (Lam et al., 2010). This mechanism
which they termed angiophagy involves rapid remodeling of
the endothelium, engulfment of the occluding emboli and
their translocation through the arteriolar vascular wall (Lam
et al., 2010; Grutzendler et al., 2014). This discovery has the
potential to greatly impact our understanding and treatment
of thromboembolic disorders and the ischemia no-reflow
phenomenon. His group also developed a label-free technique
(Spectral Confocal Reflection Microscopy-SCoRe) to image
myelinated axons in vivo (Hill and Grutzendler, 2014; Schain
et al., 2014). This technique allowed for the first time high-
resolution in vivo imaging of brain myelin development and
pathology in mice and is being explored for potential in vivo
diagnostic applications in peripheral nerve human disorders.
This method opens new capabilities to studymyelin development
and pathology and functional interactions with neurovascular
cells in living mice and other animals.
Huntington’s disease (HD) is caused by intracellular
accumulation and aggregation of a mutant form of the
huntingtin protein (mHTT). Dr. Baljit Khakh discussed his
group’s recent findings that suggest neural circuit–specific
astrocyte roles for the onset and progression of disease in
HD mouse models. They found that a significant increase in
astrocyte mHTT is associated with a reduction of important
functional proteins like Glt1 (EAAT2) and Kir4.1, which alter
astrocyte function without noticeable astrogliosis at least at
the onset of neurological symptoms (Tong et al., 2014). Kir4.1
potassium channels are expressed primarily by astrocytes and
regulate extracellular K+ levels (Kofuji and Newman, 2004) in
the CNS, and loss of the glutamate transporter Glt1 (EAAT2)
has been extensively studied in the context of HD (Estrada-
Sánchez and Rebec, 2012). Indeed, loss of Kir4.1 in striatal
astrocytes led to higher ambient extracellular K+ concentrations,
which contributed to increased medium spiny neuron (MSN)
excitability in HD mouse models (Tong et al., 2014). Moreover,
selective expression of GFP-labeled Kir4.1 channels in astrocytes
rescued these deficits, demonstrating that astrocyte Kir4.1 loss
can phenocopy hallmark MSN changes of HD mouse models
(Cepeda et al., 2010). Together these results support that key
aspects of altered MSN excitability in HD are caused at least in
part by the failure of astrocytes to maintain homeostatic levels of
extracellular K+. This would imply an important yet diverse role
for astrocytes in HD pathology, which changes with the disease
progression. At early stages of the disease deficits in Kir4.1 and
Glt1 (EAAT2) could contribute to underlying HD pathological
mechanisms, which could further facilitate the progressive
increase in astrocyte reactivity observed with disease progression
in humans. Thus, therapeutic strategies targeting astrocytes need
to take into account a range of potential astrocytic contributions
to HD progression ranging from early homeostatic dysfunction
to advanced reactive responses.
NEW IMAGING TECHNOLOGIES AND
MOLECULAR TOOLS
MR is a powerful non-invasive imaging modality that makes
it possible to visualize anatomic and vascular structures in the
brain, as well as physiological and metabolic properties that
reflect changes in biological function. Dr. Sarah Nelson discussed
recent advances in technology that allow whole body 7T MR
scanners and high performance gradients, providing major
improvements in the signal to noise ratio and sensitivity achieved
in the human brain. High resolution time of flight angiography
and susceptibility weighted imaging have been used to take
advantage of these capabilities and are critical for monitoring
changes in arterial and venous structures associated with vascular
disease, aging, trauma and radiation-induced damage (Lupo
et al., 2012). The contrast obtained with blood oxygenation
level dependent (BOLD) and phase imaging is significantly
higher at 7T, facilitating improved fMRI and the detection of
abnormalities in deep gray matter structures that are associated
with neurodegenerative diseases such as AD, HD (Apple et al.,
2014) and MS (Bian et al., 2013). Metabolic imaging that uses
multi-voxel H-1 spectroscopy has been applied to evaluate
abnormalities caused by neurological and psychiatric diseases
and has been shown to benefit from both the higher signal to
noise ratio and increased spectral resolution that is possible at
7T (Li et al., 2015) MR imaging.
Dr. Christopher Chang focused his presentation on the
chemistry/neuroscience interface, and in particular on the
development of molecular imaging probes to enable discovery
and study of new types of chemical signals based on metals
and redox molecules that govern brain activity. The traditional
view of metals in biology is that sodium, potassium, and calcium
are the major dynamic signals whereas transition metals are
solely static metabolic cofactors. However, invention of several
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classes of fluorescent probes for metals (Domaille et al., 2008;
Que et al., 2008; Aron et al., 2015; Cotruvo et al., 2015) led
to the identification of copper as an endogenous regulator of
spontaneous activity (Dodani et al., 2011, 2014), representing
a new paradigm of transition metal signaling (Chang, 2015).
Along the same lines, Dr. Chang presented work from his group
illustrating an alternative approach to sensing where reactive
small-molecule analytes are sorted by their chemical reactivity
as opposed to shape-based recognition and binding (Chan et al.,
2012). New probes for emerging signaling / stress molecules
like hydrogen peroxide (Lippert et al., 2011) and hydrogen
sulfide (Lin et al., 2015) have been devised to identify the
essential role of redox molecules in neural stem cells (Dickinson
et al., 2011) and H2O2/H2S crosstalk (Lin et al., 2013). These
examples illustrate the utility of chemoselective probes for
selective molecular imaging of biologically relevant molecules in
their native environments.
CONCLUDING REMARKS
The first Neurovascular and Immuno-Imaging Symposium
provided a forum for the discussion of current research
on the cellular and molecular mechanisms that regulate the
interface between brain and periphery, both in physiology
and in neurological disease. Imaging technologies have proven
invaluable in facilitating new discoveries that have reshaped our
understanding of cellular behaviors in the CNS (Davalos and
Akassoglou, 2008; Merlini et al., 2012). Such discoveries have
began to explain not only fundamental physiological functions
like the coupling of neuronal activity to blood supply in the brain,
but also underlying mechanisms for disease development, like
those when the BBB is compromised and peripheral immune cells
infiltrate the CNS. The continuous development of new imaging
technologies and novel molecular tools that can target ongoing
cellular and molecular events at the neurovascular interface
will further expand our capabilities to decipher physiological
and pathological mechanisms, and design better strategies for
therapies in neurological diseases.
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